Lonza completed a laboratory expansion project at its API manufacturing facility in Nansha, China. The project, which grew the footprint of the lab by 250 square meters, included the addition of new ...
“Our customers, in partnership with federal and state agencies, are reshoring drug manufacturing in the U.S., the world’s largest pharmaceutical market. Local API production is vital for supply chain ...
ST. LOUIS--(BUSINESS WIRE)--The drug API Innovation Center today announced it has reached a milestone in the development of technology essential to accelerating the U.S. production of lomustine, a ...
Novo Nordisk (NVO) has pledged DKK 42B ($6B) from 2023 through the next six years to expand production capacity in its home country. The investment will go into ramping up production at existing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback